Medico Remedies (NSE:MEDICO) Other Current Payables: ₹-0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDICO Medico Remedies Ltd NSE:MEDICO
85 GF Score
Price ₹38.96
GF Value ₹76.46
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medico Remedies Other Current Payables?

Medico Remedies NSE:MEDICO +0.36% 85 Other Current Payables is ₹-0 Mil as of Mar. 2026. GuruFocus rates NSE:MEDICO with a GF Score™ of 85/100 and a GF Value™ of ₹76.46 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Medico Remedies's Other Current Payables for the quarter that ended in Mar. 2026 was ₹-0 Mil.

Medico Remedies's quarterly Other Current Payables declined from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) and declined from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹-0 Mil).

Medico Remedies's annual Other Current Payables declined from Mar. 2024 (₹15 Mil) to Mar. 2025 (₹12 Mil) and declined from Mar. 2025 (₹12 Mil) to Mar. 2026 (₹-0 Mil).

Medico Remedies Other Current Payables Related Terms

Medico Remedies Other Current Payables Historical Data

* Premium members only.

The historical data trend for Medico Remedies's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies Other Current Payables Chart

Medico Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.71 9.05 15.01 11.85 -0.00

Medico Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.85 0.00 0.00 0.00 -0.00
NSE:MEDICO
85GF Score
Medico Remedies Ltd NSE:MEDICO
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medico Remedies Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹-0 Mil mean?
Medico Remedies (NSE:MEDICO) has a Other Current Payables of ₹-0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medico Remedies and its competitors.
Is Medico Remedies' Other Current Payables too high?
Medico Remedies' current Other Current Payables is ₹-0 Mil. Overall, Medico Remedies has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' Other Current Payables compare to ZTS and UTHR?
Medico Remedies' Other Current Payables of ₹-0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medico Remedies and its competitors. Medico Remedies's current Other Current Payables is ₹-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹76.46, compared to a current price of ₹38.96 — trading 49% below its estimated fair value. The current Other Current Payables is ₹-0 Mil. Medico Remedies' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current Other Current Payables is ₹-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?

Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued. The current stock price of ₹38.96 is trading 49% below its estimated GF Value™ of ₹76.46. GuruFocus considers Medico Remedies to be Significantly Undervalued.

Key valuation signals for NSE:MEDICO:

  • Other Current Payables: ₹-0 Mil
  • GF Value™: ₹76.46 vs. price of ₹38.96 (49% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medico Remedies Business Description

Other Exchanges 540937:India
Address N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
85GF Score

Get the complete analysis for NSE:MEDICO

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.96
Price
₹76.46
GF Value